Squarepoint’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,386
Closed -$14.1K 3021
2024
Q4
$14.1K Buy
+1,386
New +$14.1K ﹤0.01% 2722
2023
Q4
Sell
-2,277
Closed -$45.8K 2748
2023
Q3
$45.8K Buy
+2,277
New +$45.8K ﹤0.01% 2335
2023
Q2
Sell
-837
Closed -$48.8K 2629
2023
Q1
$48.8K Sell
837
-2,649
-76% -$155K ﹤0.01% 2118
2022
Q4
$178K Buy
+3,486
New +$178K ﹤0.01% 1924
2022
Q1
Sell
-8,285
Closed -$799K 2552
2021
Q4
$799K Buy
+8,285
New +$799K ﹤0.01% 1339
2021
Q3
Sell
-2,294
Closed -$355K 2507
2021
Q2
$355K Buy
+2,294
New +$355K ﹤0.01% 1846
2021
Q1
Sell
-5,337
Closed -$1.24M 2804
2020
Q4
$1.24M Sell
5,337
-5,231
-49% -$1.21M 0.01% 952
2020
Q3
$2.31M Buy
10,568
+7,811
+283% +$1.71M 0.03% 576
2020
Q2
$783K Sell
2,757
-1,059
-28% -$301K 0.01% 1067
2020
Q1
$1.1M Buy
3,816
+2,257
+145% +$651K 0.03% 682
2019
Q4
$448K Buy
+1,559
New +$448K ﹤0.01% 1785
2019
Q3
Sell
-1,304
Closed -$117K 2407
2019
Q2
$117K Buy
+1,304
New +$117K ﹤0.01% 2131
2019
Q1
Sell
-3,521
Closed -$495K 2245
2018
Q4
$495K Buy
3,521
+48
+1% +$6.75K 0.01% 1234
2018
Q3
$887K Buy
3,473
+2,493
+254% +$637K 0.01% 1045
2018
Q2
$250K Buy
+980
New +$250K ﹤0.01% 1458
2018
Q1
Sell
-860
Closed -$124K 1920
2017
Q4
$124K Buy
+860
New +$124K ﹤0.01% 1906
2017
Q1
Sell
-1,140
Closed -$161K 1717
2016
Q4
$161K Buy
+1,140
New +$161K 0.01% 1515